SSTK Q4 2025 Earnings EPS Misses Estimates as Growth Headwinds Persist FirstCash Holdings FCFS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline Energy Focus Q4 2024 Earnings Narrowed Loss Reflects Ongoing Cost Controls IPHA Q1 2026 Earnings Significant EPS Miss Amid Ongoing RD Focus ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher